Apath, LLC is a drug discovery company focused on human viral diseases.  Apath applies state-of-the art molecular virology and viral genetics to the discovery and development of novel therapeutic products for the treatment of viral infections.    Apath’s primary focus is on RNA viruses.  Most medically important viruses are RNA viruses including hepatitis C virus, influenza virus, respiratory syncytial virus (RSV), and hemorrhagic fever viruses.

Apath's founder and key employees have a proven track record and comprehensive expertise in virology and molecular biology. Apath has key patents, proprietary know-how, and license agreements related to hepatitis C virus (HCV) and other important human viral pathogens.  In addition, Apath has a proprietary antiviral screening platform.

Antiviral Drug Discovery Click here to learn more.

Screening Platform   Click here to learn more.

    Apath Pipeline          Click here to learn more.